» Articles » PMID: 39344371

Apathy and Impulsivity Co-Occur in Huntington's Disease

Overview
Journal Brain Behav
Specialty Psychology
Date 2024 Sep 30
PMID 39344371
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Apathy is a debilitating behavioral change in Huntington's disease (HD), but impulsivity in HD has not been well documented, and the co-occurrence of these behaviors in HD has not been investigated.

Objective: Our objective was to determine whether apathy and impulsivity co-occur in people with HD and their associations with quality of life.

Methods: Carriers of Huntington's gene expansion (premanifest to mild motor manifest disease; n = 42) along with healthy controls (n = 20) completed measures of apathy (Apathy Evaluation Scale and Apathy Motivation Index) and impulsivity (Barratt Impulsiveness Scale-11 and UPPS-P impulsivity scale), along with mood, cognition, clinical, and quality of life measures. Apathy and impulsivity measures were each reduced to a single metric per patient using principal component analysis. Correlations and multiple linear regression models determined associations between apathy and impulsivity and the potential influence of other covariates.

Results: Apathy and impulsivity were significantly correlated (r = 0.6, p < 0.001, 95% CI [0.36, 0.76]) in HD, with this association remaining after controlling for depressive symptoms, motor disease severity, and cognitive function. Furthermore, apathy and depressive symptoms were associated with poorer quality of life.

Conclusions: Apathy and impulsivity co-occur in individuals with premanifest to mild manifest HD and have a significant impact on wellbeing. We add to a growing evidence body that apathy and impulsivity may be intrinsically linked.

References
1.
Le Heron C, Holroyd C, Salamone J, Husain M . Brain mechanisms underlying apathy. J Neurol Neurosurg Psychiatry. 2018; 90(3):302-312. PMC: 6518466. DOI: 10.1136/jnnp-2018-318265. View

2.
Sinha N, Manohar S, Husain M . Impulsivity and apathy in Parkinson's disease. J Neuropsychol. 2013; 7(2):255-83. PMC: 3836240. DOI: 10.1111/jnp.12013. View

3.
Velligan D, Ritch J, Sui D, DiCocco M, Huntzinger C . Frontal Systems Behavior Scale in schizophrenia: relationships with psychiatric symptomatology, cognition and adaptive function. Psychiatry Res. 2003; 113(3):227-36. DOI: 10.1016/s0165-1781(02)00264-0. View

4.
Anderson K, van Duijn E, Craufurd D, Drazinic C, Edmondson M, Goodman N . Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders. J Huntingtons Dis. 2018; 7(3):355-366. PMC: 6294590. DOI: 10.3233/JHD-180293. View

5.
Marin R, Biedrzycki R, Firinciogullari S . Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991; 38(2):143-62. DOI: 10.1016/0165-1781(91)90040-v. View